Position in MEDP
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$241,627,283
-$65,639,074 QoQ
Shares Held
503,191
-8.0% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 76.28375706242758.ToString("F0")%
Shared 0.ToString("F0")%
None 23.716242937572414.ToString("F0")%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BAILLIE GIFFORD & CO holds $1,287,817,046 across 6 Diagnostics & Research names. MEDP ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
3,859,046 | $356,460,077 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
698,441 | $343,304,703 | |
| 3 | MEDP |
Medpace Holdings, Inc.
This page
|
503,191 | $241,627,283 | |
| 4 | ILMN |
Illumina, Inc.
|
1,535,106 | $189,217,163 | |
| 5 | BLLN |
BillionToOne, Inc.
|
1,259,993 | $99,463,846 | |
| 6 | TWST |
Twist Bioscience Corp
|
1,215,151 | $57,743,974 |
All Filings in MEDP
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $241,627,283 | 503,191 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $307,266,357 | 547,078 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $300,678,709 | 584,796 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $163,926,880 | 522,293 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $1,310,775 | 4,302 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $4,812,682 | 14,486 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $4,965,608 | 14,876 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $2,223,165 | 5,398 | Shares | Defined | 2024-07-25 | |
| No filing history on record for this holder in this stock. | ||||||